SK
Sanjay Kumar Khare
About Sanjay Kumar Khare
Data last updated:
Sanjay Kumar Khare is a Designated Partner at S4 C2d Developers Llp (since 2024) and Designated Partner at Mscians Drugs India Llp (since 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 20 Aug 2024 | 2024 | Active | ||
| Designated Partner | 03 Jun 2024 | 2024 | Active |
Board colleagues of Sanjay Kumar Khare
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suresh Chandra Srivastava | 00966065 | S4 C2d Developers Llp | Designated Partner |
| Adity Sharma | 11219492 | Mscians Drugs India Llp | Designated Partner |
| Aryansh Khare | 10654440 | Mscians Drugs India Llp | Designated Partner |
| Sunita Shrivastava | 10654439 | Mscians Drugs India Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar Khare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar Khare
Sanjay Kumar Khare currently holds 2 directorships: S4 C2d Developers Llp (Designated Partner, since 20 Aug 2024); Mscians Drugs India Llp (Designated Partner, since 03 Jun 2024).
Sanjay Kumar Khare was first appointed on 03 Jun 2024 as Designated Partner at Mscians Drugs India Llp.
The current boards of Sanjay Kumar Khare's companies include Suresh Chandra Srivastava (S4 C2d Developers Llp), Adity Sharma (Mscians Drugs India Llp), Aryansh Khare (Mscians Drugs India Llp), Sunita Shrivastava (Mscians Drugs India Llp).